1) Saeed K, McLaren AC, Schwarz EM, et al. 2018 international consensus meeting on musculoskeletal infection:summary from the biofilm workgroup and consensus on biofilm related musculoskeletal infections. J Orthop Res 2019;37(5):1007-17.
2) Osmon DR, Berbari EF, Berendt AR, et al;Infectious Diseases Society of America. Diagnosis and management of prosthetic joint infection:clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013;56(1):e1-e25.
3) Castaneda P, McLaren A, Tavaziva G, et al. Biofilm antimicrobial susceptibility increases with antimicrobial exposure time. Clin Orthop Relat Res 2016;474(7):1659-64.
4) Ceri H, Olson ME, Stremick C, et al. The Calgary Biofilm Device:new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999;37(6):1771-6.
5) Howlin RP, Brayford MJ, Webb JS, et al. Antibiotic-loaded synthetic calcium sulfate beads for prevention of bacterial colonization and biofilm formation in periprosthetic infections. Antimicrob Agents Chemother 2015;59(1):111-20.
6) Badha V, Moore R, Heffernan J, et al. Determination of tobramycin and vancomycin exposure required to eradicate biofilms on muscle and bone tissue in vitro. J Bone Jt Infect 2019;4(1):1-9.
7) Schwarz EM, McLaren AC, Sculco TP, et al;Hospital for Special Surgery Biofilm Symposium W. Adjuvant antibiotic-loaded bone cement:concerns with current use and research to make it work. J Orthop Res 2021;39(2):227-39.
8) Choe H, Inaba Y, Kobayashi N, et al. Clinical utility of antibiotic-loaded hydroxyapatite block for treatment of intractable periprosthetic joint infection and septic arthritis of the hip. Mod Rheumatol 2015;25(6):937-42.
9) 宮地伸晃,圓尾明弘,大島隆司・他.インプラント留置後の骨感染症に対する骨髄点滴からの高濃度抗生剤投与による感染制御.関節外科2016;35(4):434-8.
10) Himeno D, Matsuura Y, Maruo A, et al. A novel treatment strategy using continuous local antibiotic perfusion:a case series study of a refractory infection caused by hypervirulent Klebsiella pneumoniae. J Orthop Sci 2022;27(1):272-80.
11) 片岡君成,圓尾明弘,大島隆司・他.軟部組織感染症に対する局所高濃度抗菌薬投与(iSAP)による治療.骨折2018;40(2):588-91.
12) 圓尾明弘,福井友章,大江啓介・他.Intra-medullary antibiotics perfusion(iMAP)から屍体脛骨骨髄内に投与された抗菌薬の薬物動態.骨折2020;42(1):1-5.
13) Takahashi H, Koda M, Funayama T, et al. Continuous local antibiotic perfusion for patients with surgical site infection after instrumented spinal surgery:a novel technique to retain the implants. J Clin Neurosci 2021;93:70-4.
14) Roy R, Tiwari M, Donelli G, et al. Strategies for combating bacterial biofilms:a focus on anti-biofilm agents and their mechanisms of action. Virulence 2018;9(1):522-54.
15) Brown TS, Petis SM, Osmon DR, et al. Periprosthetic joint infection with fungal pathogens. J Arthroplasty 2018;33(8):2605-12.
16) Kuiper JW, van den Bekerom MP, van der Stappen J, et al. 2-stage revision recommended for treatment of fungal hip and knee prosthetic joint infections. Acta Orthop 2013;84(6):517-23.
17) Nace J, Siddiqi A, Talmo CT, et al. Diagnosis and management of fungal periprosthetic joint infections. J Am Acad Orthop Surg 2019;27(18):e804-8.
18) Peter T, Bissinger R, Signoretto E, et al. Micafungin-induced suicidal erythrocyte death. Cell Physiol Biochem 2016;39(2):584-95.
19) Grela E, Piet M, Luchowski R, et al. Imaging of human cells exposed to an antifungal antibiotic amphotericin B reveals the mechanisms associated with the drug toxicity and cell defence. Sci Rep 2018;8(1):14067.
20) CLAP研究会.https://www.ismap-clap.com/home.(2021年11月30日アクセス)